News from valeant pharmaceuticals international, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 09, 2014, 05:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces FDA Approval Of Jublia® for the Treatment of Onychomycosis

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that that its wholly owned subsidiary, Valeant...

May 30, 2014, 14:36 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant And Pershing Square Make Revised Offer For Allergan Contingent On Good Faith Negotiations

 Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) today announced that it is making an offer for Allergan, Inc....

May 28, 2014, 06:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Substantially Increases Merger Proposal For Allergan

- Increases Cash Consideration by $10.00 per share to $58.30, approximately 21 Percent Increase - Maintains 0.83 of a Valeant share...

May 28, 2014, 01:15 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals To Sell Filler And Toxin Assets To Nestle For $1.4 Billion

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it has entered into an agreement with Nestle S.A. to...

May 27, 2014, 18:04 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant To Host In-Person Investor Meeting And Webcast On May 28, 2014 At 8:00 A.M. ET

 Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) announced today that the company is hosting an in-person...

May 23, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals to Present at the Sanford C. Bernstein Thirtieth Annual Strategic Decisions Conference 2014

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a...

May 21, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces 2014 Annual Meeting Results

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of ten directors nominated at its 2014 annual...

May 20, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant to Discuss Allergan Proposal at Investor Meeting and Webcast on May 28, 2014 at 8:00 A.M. ET

Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) announced today that the company will host an in-person meeting for...

May 13, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Responds to Allergan's Rejection of Merger Proposal

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today responded to Allergan, Inc.'s (NYSE: AGN) rejection of Valeant's...

May 12, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Enters Into Patent Settlement Agreements With Actavis

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that certain of its subsidiaries have entered into...

May 08, 2014, 06:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Reports First Quarter 2014 Financial Results

- 2014 First Quarter Total Revenue $1.9 billion; an increase of 77% over the prior year - Exceeded our expectations - Launched...

May 01, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals To Webcast 2014 Annual Meeting Of Shareholders

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual...

Apr 24, 2014, 15:15 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management L.P. ("Pershing Square") today announced that...

Apr 24, 2014, 12:10 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals To Announce 2014 First Quarter Results On May 8, 2014

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast...

Apr 23, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Announces Nominations For Board Of Directors

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today its nominees to stand for election to the Board of...

Apr 22, 2014, 07:30 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Proposes to Combine With Allergan for $48.30 in Cash and 0.83 Shares of Valeant Stock for Each Allergan Share

Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) announced today that it has submitted a merger proposal to the Board...

Mar 25, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%

 Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug...

Feb 27, 2014, 06:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Reports Fourth Quarter And Full Year 2013 Financial Results

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announces fourth quarter financial results for 2013. Fourth Quarter 2013...

Feb 05, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals To Announce 2013 Fourth Quarter And Full Year Results On February 27, 2014

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast...

Feb 03, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has entered into a definitive agreement under which...